During the past decade, Stanford Psychiatry conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford Psychiatry" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Stanford Psychiatry" are "Healthy" (1 trials) and "Major Depressive Disorder" (1 trials). Many other conditions were trialed in "Stanford Psychiatry" in a lesser frequency.

Most popular intervention types in "Stanford Psychiatry" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Guanfacine Pill" (1 trials), "Ketamine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stanford Psychiatry" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Stanford Psychiatry". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Stanford Psychiatry, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stanford Psychiatry, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".